| 1 | United Therapeutics Corporation US91307C1027 | 🇺🇸 US | $23,6 Mrd. | A+ |
| 2 | Lakefront Biotherapeutics N.V. US36315X1019 | 🇧🇪 BE | $2,0 Mrd. | A+ |
| 3 | Neurocrine Biosciences Inc. US64125C1099 | 🇺🇸 US | $17,5 Mrd. | A+ |
| 4 | Incyte Corporation US45337C1027 | 🇺🇸 US | $23,3 Mrd. | A+ |
| 5 | ALK-Abelló A/S DK0061802139 | 🇩🇰 DK | $8,3 Mrd. | A+ |
| 6 | Exelixis Inc. US30161Q1040 | 🇺🇸 US | $14,0 Mrd. | A+ |
| 7 | Catalyst Pharmaceuticals Inc. US14888U1016 | 🇺🇸 US | $3,9 Mrd. | A+ |
| 8 | UCB S.A. BE0003739530 | 🇧🇪 BE | $57,6 Mrd. | A+ |
| 9 | Halozyme Therapeutics Inc. US40637H1095 | 🇺🇸 US | $9,4 Mrd. | A+ |
| 10 | Ligand Pharmaceuticals Incorporated US53220K5048 | 🇺🇸 US | $6,4 Mrd. | A+ |
| 11 | Anthem Biosciences Ltd. INE0CZ201020 | 🇮🇳 IN | $4,6 Mrd. | A+ |
| 12 | Corcept Therapeutics Incorporated US2183521028 | 🇺🇸 US | $9,7 Mrd. | A+ |
| 13 | Harmony Biosciences Holdings Inc. US4131971040 | 🇺🇸 US | $2,2 Mrd. | A+ |
| 14 | Vertex Pharmaceuticals Incorporated US92532F1003 | 🇺🇸 US | $134,0 Mrd. | A+ |
| 15 | TG Therapeutics Inc. US88322Q1085 | 🇺🇸 US | $8,2 Mrd. | A+ |
| 16 | Rigel Pharmaceuticals Inc. US7665597024 | 🇺🇸 US | $716 Mio. | A+ |
| 17 | Krystal Biotech Inc. US5011471027 | 🇺🇸 US | $11,1 Mrd. | A+ |
| 18 | Regeneron Pharmaceuticals Inc. US75886F1075 | 🇺🇸 US | $67,4 Mrd. | A+ |
| 19 | Sunshine Guojian Pharmaceutical (Shanghai) Co. Ltd CNE1000062X2 | 🇨🇳 CN | $7,8 Mrd. | A+ |
| 20 | argenx SE NL0010832176 | 🇳🇱 NL | $58,4 Mrd. | A+ |
| 21 | Aurinia Pharmaceuticals Inc. CA05156V1022 | 🇨🇦 CA | $2,0 Mrd. | A |
| 22 | WuXi Biologics (Cayman) Inc. KYG970081173 | 🇨🇳 CN | $18,5 Mrd. | A |
| 23 | Ascendis Pharma A/S DKK085881034 | 🇩🇰 DK | $17,0 Mrd. | A |
| 24 | BeOne Medicines AG US07725L1026 | 🇺🇸 US | $31,8 Mrd. | A |
| 25 | Alkermes plc IE00B56GVS15 | 🇮🇪 IE | $9,1 Mrd. | A |
| 26 | Shanghai Allist Pharmaceuticals Co. Ltd. CNE100005XJ7 | 🇨🇳 CN | $8,7 Mrd. | A |
| 27 | ACADIA Pharmaceuticals Inc. US0042251084 | 🇺🇸 US | $4,4 Mrd. | A |
| 28 | BeOne Medicines Ltd. Class A CNE100005XT6 | 🇨🇭 CH | $39,1 Mrd. | A |
| 29 | Liquidia Corporation US53635D2027 | 🇺🇸 US | $7,0 Mrd. | A |
| 30 | Lakefront Biotherapeutics BE0003818359 | 🇧🇪 BE | $2,0 Mrd. | A |
| 31 | Innoviva Inc. US45781M1018 | 🇺🇸 US | $1,6 Mrd. | A |
| 32 | DaShenLin Pharmaceutical Group Co. Ltd. CNE100002RG2 | 🇨🇳 CN | $2,7 Mrd. | A |
| 33 | Simcere Pharmaceutical Group Limited HK0000658531 | 🇨🇳 CN | $3,6 Mrd. | B+ |
| 34 | Asymchem Laboratories (Tianjin) Co. Ltd. CNE100002BZ6 | 🇨🇳 CN | $7,5 Mrd. | B+ |
| 35 | Zevra Therapeutics Inc. US4884452065 | 🇺🇸 US | $826 Mio. | B+ |
| 36 | Samsung Biologics Co.Ltd. KR7207940008 | 🇰🇷 KR | $43,2 Mrd. | B+ |
| 37 | 3SBio Inc. KYG8875G1029 | 🇨🇳 CN | $5,8 Mrd. | B+ |
| 38 | Sichuan Kelun Pharmaceutical Co. Ltd. Class A CNE100000PW7 | 🇨🇳 CN | $10,5 Mrd. | B+ |
| 39 | Alnylam Pharmaceuticals Inc. US02043Q1076 | 🇺🇸 US | $41,8 Mrd. | B+ |
| 40 | BioMarin Pharmaceutical Inc. US09061G1013 | 🇺🇸 US | $11,4 Mrd. | B+ |
| 41 | Axsome Therapeutics Inc. US05464T1043 | 🇺🇸 US | $12,6 Mrd. | B+ |
| 42 | Theravance Biopharma Inc KYG8807B1068 | 🇺🇸 US | $873 Mio. | B+ |
| 43 | Celltrion Inc. KR7068270008 | 🇰🇷 KR | $26,2 Mrd. | B+ |
| 44 | Travere Therapeutics Inc. US89422G1076 | 🇺🇸 US | $5,3 Mrd. | B+ |
| 45 | Ionis Pharmaceuticals Inc. US4622221004 | 🇺🇸 US | $13,5 Mrd. | B+ |
| 46 | Biocon Limited INE376G01013 | 🇮🇳 IN | $6,0 Mrd. | B+ |
| 47 | Genmab A/S DK0010272202 | 🇩🇰 DK | $17,6 Mrd. | B |
| 48 | Gubra A/S DK0062266474 | 🇩🇰 DK | $831 Mio. | B |
| 49 | Clinuvel Pharmaceuticals Limited AU000000CUV3 | 🇦🇺 AU | $357 Mio. | B |
| 50 | BioArctic AB SE0010323311 | 🇸🇪 SE | $3,0 Mrd. | B |
| 51 | Xiamen Amoytop Biotech Co. Ltd. CNE100003RT3 | 🇨🇳 CN | $3,5 Mrd. | B |
| 52 | Zealand Pharma A/S DK0060257814 | 🇩🇰 DK | $3,3 Mrd. | B |
| 53 | Vericel Corporation US92346J1088 | 🇺🇸 US | $2,4 Mrd. | B |
| 54 | Bavarian Nordic A/S DK0015998017 | 🇩🇰 DK | $2,2 Mrd. | B |
| 55 | AnaptysBio Inc. US0327241065 | 🇺🇸 US | $2,7 Mrd. | B |
| 56 | Innovent Biologics Inc. KYG4818G1010 | 🇨🇳 CN | $19,4 Mrd. | B |
| 57 | Xeris Biopharma Holdings Inc. US98422E1038 | 🇺🇸 US | $1,4 Mrd. | B |
| 58 | Haisco Pharmaceutical Group Co. Ltd. CNE100001BC7 | 🇨🇳 CN | $13,0 Mrd. | B |
| 59 | Hugel Inc. KR7145020004 | 🇰🇷 KR | $1,8 Mrd. | B |
| 60 | Bio-Techne Corporation US09073M1045 | 🇺🇸 US | $11,1 Mrd. | C |
| 61 | Lonza Group AG CH0013841017 | 🇨🇭 CH | $49,1 Mrd. | C |
| 62 | Jazz Pharmaceuticals plc IE00B4Q5ZN47 | 🇮🇪 IE | $15,3 Mrd. | C |
| 63 | Madrigal Pharmaceuticals Inc. US5588681057 | 🇺🇸 US | $12,2 Mrd. | C |
| 64 | BridgeBio Pharma Inc. US10806X1028 | 🇺🇸 US | $15,1 Mrd. | C |
| 65 | Beijing Tiantan Biological Products Co. Ltd. CNE000000WF9 | 🇨🇳 CN | $3,5 Mrd. | C |
| 66 | Abeona Therapeutics Inc. US00289Y2063 | 🇺🇸 US | $365 Mio. | C |
| 67 | Suzhou Zelgen Biopharmaceuticals Co. Ltd. CNE100003RP1 | 🇨🇳 CN | $5,3 Mrd. | C |
| 68 | Alteogen Inc. KR7196170005 | 🇰🇷 KR | $11,7 Mrd. | C |
| 69 | Anhui Anke Biotechnology (Group) Co. Ltd. CNE100000GY2 | 🇨🇳 CN | $2,0 Mrd. | C |
| 70 | Yunnan Botanee Bio-Technology Group Co.LTD CNE100004G74 | 🇨🇳 CN | $2,0 Mrd. | C |
| 71 | Biocytogen Pharmaceuticals (Beijing) Co. Ltd. CNE100005D27 | 🇨🇳 CN | $2,4 Mrd. | C |
| 72 | SK Biopharmaceuticals Co. Ltd. KR7326030004 | 🇰🇷 KR | $4,4 Mrd. | C |
| 73 | Pharma Mar S.A. ES0169501022 | 🇪🇸 ES | $1,6 Mrd. | C |
| 74 | Concord Biotech Limited INE338H01029 | 🇮🇳 IN | $1,4 Mrd. | C |
| 75 | CSL Limited AU000000CSL8 | 🇦🇺 AU | $40,2 Mrd. | C |
| 76 | Mirum Pharmaceuticals Inc. US6047491013 | 🇺🇸 US | $6,3 Mrd. | C |
| 77 | Puma Biotechnology Inc. US74587V1070 | 🇺🇸 US | $420 Mio. | C |
| 78 | UroGen Pharma Ltd. IL0011407140 | 🇺🇸 US | $1,9 Mrd. | C |
| 79 | Neuren Pharmaceuticals Limited NZNEUE0001S8 | 🇦🇺 AU | $1,5 Mrd. | C |
| 80 | MiMedx Group Inc. US6024961012 | 🇺🇸 US | $588 Mio. | C |
| 81 | CorMedix Inc. US21900C3088 | 🇺🇸 US | $686 Mio. | C |
| 82 | ADMA Biologics Inc. US0008991046 | 🇺🇸 US | $2,1 Mrd. | C |
| 83 | Arcutis Biotherapeutics Inc. US03969K1088 | 🇺🇸 US | $3,2 Mrd. | C |
| 84 | InnoCare Pharma Limited KYG4783B1032 | 🇨🇳 CN | $2,4 Mrd. | C |
| 85 | Shanghai RAAS Blood Products Co. Ltd. CNE100000C31 | 🇨🇳 CN | $4,4 Mrd. | C |
| 86 | Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd. CNE1000062J1 | 🇨🇳 CN | $14,5 Mrd. | C |
| 87 | PTC Therapeutics Inc. US69366J2006 | 🇺🇸 US | $6,9 Mrd. | C |
| 88 | Hualan Biological Engineering Inc. CNE000001JN8 | 🇨🇳 CN | $3,4 Mrd. | C |
| 89 | Basilea Pharmaceutica AG CH0011432447 | 🇨🇭 CH | $818 Mio. | C |
| 90 | Genus plc GB0002074580 | 🇬🇧 GB | $2,1 Mrd. | C |
| 91 | ImmunityBio Inc. US45256X1037 | 🇺🇸 US | $9,9 Mrd. | C |
| 92 | Rhythm Pharmaceuticals Inc. US76243J1051 | 🇺🇸 US | $7,8 Mrd. | C |
| 93 | Syngene International Limited INE398R01022 | 🇮🇳 IN | $1,9 Mrd. | C |
| 94 | Adaptive Biotechnologies Corporation US00650F1093 | 🇺🇸 US | $3,4 Mrd. | C |
| 95 | Nanobiotix S.A. FR0011341205 | 🇫🇷 FR | $2,0 Mrd. | C |
| 96 | Legend Biotech Corporation US52490G1022 | 🇺🇸 US | $5,5 Mrd. | C |
| 97 | Pharmicell Co. Ltd. KR7005690003 | 🇰🇷 KR | $477 Mio. | C |
| 98 | PharmaEngine Inc. TW0004162003 | 🇹🇼 TW | $287 Mio. | C |
| 99 | Moderna Inc. US60770K1079 | 🇺🇸 US | $31,6 Mrd. | C |
| 100 | Arbutus Biopharma Corp CA03879J1003 | 🇺🇸 US | $962 Mio. | C |
| 101 | Praxis Precision Medicines Inc. US74006W2070 | 🇺🇸 US | $6,7 Mrd. | C |
| 102 | Roivant Sciences Ltd. BMG762791017 | 🇬🇧 GB | $25,3 Mrd. | C |
| 103 | Onesource Specialty Pharma Ltd. INE013P01021 | 🇮🇳 IN | $2,0 Mrd. | C |
| 104 | Telix Pharmaceuticals Limited AU000000TLX2 | 🇦🇺 AU | $4,0 Mrd. | C |
| 105 | Abbisko Cayman Limited KYG0028A1085 | 🇨🇳 CN | $1,0 Mrd. | C |
| 106 | HBM Holdings Limited KYG4403H1002 | 🇨🇳 CN | $1,2 Mrd. | C |
| 107 | ArriVent BioPharma Inc. US04272N1028 | 🇺🇸 US | $1,6 Mrd. | D |
| 108 | Cytokinetics Incorporated US23282W6057 | 🇺🇸 US | $10,8 Mrd. | D |
| 109 | Tarsus Pharmaceuticals Inc. US87650L1035 | 🇺🇸 US | $2,8 Mrd. | D |
| 110 | Shanghai Junshi Biosciences Co. Ltd. CNE1000041Z1 | 🇨🇳 CN | $5,4 Mrd. | D |
| 111 | Idorsia Ltd CH0363463438 | 🇨🇭 CH | $1,7 Mrd. | D |
| 112 | Iovance Biotherapeutics Inc. US4622601007 | 🇺🇸 US | $1,5 Mrd. | D |
| 113 | Niagen Bioscience Inc US1710774076 | 🇺🇸 US | $273 Mio. | D |
| 114 | Hangzhou Tigermed Consulting Co. Ltd CNE1000040M1 | 🇨🇳 CN | $5,4 Mrd. | D |
| 115 | Alumis Inc. US0223071020 | 🇺🇸 US | $3,3 Mrd. | D |
| 116 | CG Oncology Inc. US1569441009 | 🇺🇸 US | $6,2 Mrd. | D |
| 117 | Vaxcyte Inc. US92243G1085 | 🇺🇸 US | $8,4 Mrd. | D |
| 118 | Esperion Therapeutics Inc. US29664W1053 | 🇺🇸 US | $657 Mio. | D |
| 119 | Ultragenyx Pharmaceutical Inc. US90400D1081 | 🇺🇸 US | $3,3 Mrd. | D |
| 120 | Fennec Pharmaceuticals Inc. CA31447P1009 | 🇺🇸 US | $304 Mio. | D |
| 121 | Beam Therapeutics Inc. US07373V1052 | 🇺🇸 US | $3,6 Mrd. | D |
| 122 | Ardelyx Inc. US0396971071 | 🇺🇸 US | $1,3 Mrd. | D |
| 123 | Celcuity Inc. US15102K1007 | 🇺🇸 US | $5,3 Mrd. | D |
| 124 | Edgewise Therapeutics Inc. US28036F1057 | 🇺🇸 US | $4,3 Mrd. | D |
| 125 | Lepu Biopharma Co. Ltd. CNE100004SM4 | 🇨🇳 CN | $964 Mio. | D |
| 126 | MedinCell S.A. FR0004065605 | 🇫🇷 FR | $1,2 Mrd. | D |
| 127 | Palvella Therapeutics Inc. US6979471090 | 🇺🇸 US | $1,7 Mrd. | D |
| 128 | Medy-Tox Inc. KR7086900008 | 🇰🇷 KR | $332 Mio. | D |
| 129 | Protalix BioTherapeutics Inc. US74365A3095 | 🇺🇸 US | $187 Mio. | D |
| 130 | IDEAYA Biosciences Inc. US45166A1025 | 🇺🇸 US | $3,6 Mrd. | D |
| 131 | Trevi Therapeutics Inc. US89532M1018 | 🇺🇸 US | $2,5 Mrd. | D |
| 132 | XOMA Royalty Corp. US98419J2069 | 🇺🇸 US | $539 Mio. | D |
| 133 | Arrowhead Pharmaceuticals Inc. US04280A1007 | 🇺🇸 US | $11,8 Mrd. | D |
| 134 | Genscript Biotech Corporation KYG3825B1059 | 🇨🇳 CN | $3,6 Mrd. | D |
| 135 | Jinyu Bio-technology Co. Ltd. CNE000000Y37 | 🇨🇳 CN | $2,0 Mrd. | D |
| 136 | BioCryst Pharmaceuticals Inc. US09058V1035 | 🇺🇸 US | $2,1 Mrd. | D |
| 137 | Nuvalent Inc. US6707031075 | 🇺🇸 US | $9,1 Mrd. | D |
| 138 | Akeso Inc. KYG0146B1032 | 🇨🇳 CN | $11,7 Mrd. | D |
| 139 | Onconic Therapeutics KR7476060009 | 🇰🇷 KR | $89 Mio. | D |
| 140 | Fortrea Holdings Inc. US34965K1079 | 🇺🇸 US | $1,6 Mrd. | D |
| 141 | MannKind Corporation US56400P7069 | 🇺🇸 US | $1,4 Mrd. | D |
| 142 | Kodiak Sciences Inc. US50015M1099 | 🇺🇸 US | $2,0 Mrd. | D |
| 143 | Novavax Inc. US6700024010 | 🇺🇸 US | $1,6 Mrd. | D |
| 144 | Syndax Pharmaceuticals Inc. US87164F1057 | 🇺🇸 US | $1,9 Mrd. | D |
| 145 | Revolution Medicines Inc. US76155X1000 | 🇺🇸 US | $40,2 Mrd. | D |
| 146 | Caris Life Sciences Inc. US1421521071 | 🇺🇸 US | $5,2 Mrd. | D |
| 147 | Immunovant Inc. US45258J1025 | 🇺🇸 US | $8,0 Mrd. | D |
| 148 | Revolution Medicines Inc. Warrant US76155X1182 | 🇺🇸 US | $43,4 Mrd. | D |
| 149 | MeiraGTx Holdings plc KYG596651029 | 🇺🇸 US | $1,3 Mrd. | D |
| 150 | Pharvaris N.V. NL00150005Y4 | 🇳🇱 NL | $2,4 Mrd. | D |
| 151 | Oxford Biomedica plc GB00BDFBVT43 | 🇬🇧 GB | $1,0 Mrd. | D |
| 152 | Crinetics Pharmaceuticals Inc. US22663K1079 | 🇺🇸 US | $4,5 Mrd. | D |
| 153 | Kuros Biosciences AG CH0325814116 | 🇨🇭 CH | $933 Mio. | D |
| 154 | CRISPR Therapeutics AG CH0334081137 | 🇨🇭 CH | $5,8 Mrd. | D |
| 155 | Financière de Tubize S.A. BE0003823409 | 🇧🇪 BE | $11,6 Mrd. | D |
| 156 | Stoke Therapeutics Inc. US86150R1077 | 🇺🇸 US | $2,0 Mrd. | D |
| 157 | Vera Therapeutics Inc. US92337R1014 | 🇺🇸 US | $3,0 Mrd. | D |
| 158 | Apogee Therapeutics Inc. US03770N1019 | 🇺🇸 US | $8,2 Mrd. | D |
| 159 | Precigen Inc. US74017N1054 | 🇺🇸 US | $1,7 Mrd. | D |
| 160 | Insmed Incorporated US4576693075 | 🇺🇸 US | $24,2 Mrd. | D |
| 161 | Dyne Therapeutics Inc. US26818M1080 | 🇺🇸 US | $3,8 Mrd. | D |
| 162 | Spyre Therapeutics Inc. US00773J2024 | 🇺🇸 US | $5,2 Mrd. | D |
| 163 | Gyre Therapeutics Inc. US4037831033 | 🇺🇸 US | $671 Mio. | D |
| 164 | Sarepta Therapeutics Inc. US8036071004 | 🇺🇸 US | $2,0 Mrd. | D |
| 165 | Taysha Gene Therapies Inc. US8776191061 | 🇺🇸 US | $1,6 Mrd. | D |
| 166 | Oramed Pharmaceuticals Inc. US68403P2039 | 🇺🇸 US | $188 Mio. | D |
| 167 | Cogent Biosciences Inc. US19240Q2012 | 🇺🇸 US | $6,6 Mrd. | D |
| 168 | NewAmsterdam Pharma Company N.V. NL00150012L7 | 🇳🇱 NL | $4,1 Mrd. | D |
| 169 | Emergent BioSolutions Inc. US29089Q1058 | 🇺🇸 US | $427 Mio. | D |
| 170 | Intellia Therapeutics Inc. US45826J1051 | 🇺🇸 US | $2,0 Mrd. | D |
| 171 | Achieve Life Sciences Inc. US0044685008 | 🇨🇦 CA | $657 Mio. | D |
| 172 | OliX PharmaceuticalsInc KR7226950004 | 🇰🇷 KR | $1,9 Mrd. | D |
| 173 | Scholar Rock Holding Corporation US80706P1030 | 🇺🇸 US | $6,6 Mrd. | D |
| 174 | Kura Oncology Inc. US50127T1097 | 🇺🇸 US | $985 Mio. | D |
| 175 | Nuvation Bio Inc. US67080N1019 | 🇺🇸 US | $2,0 Mrd. | D |
| 176 | Kymera Therapeutics Inc. US5015751044 | 🇺🇸 US | $9,3 Mrd. | D |
| 177 | NRx Pharmaceuticals Inc. US6294442099 | 🇺🇸 US | $67 Mio. | D |
| 178 | Definium Therapeutics Inc. CA24477V1058 | 🇺🇸 US | $4,8 Mrd. | D |
| 179 | Nkarta Inc. US65487U1088 | 🇺🇸 US | $230 Mio. | D |
| 180 | Omeros Corporation US6821431029 | 🇺🇸 US | $672 Mio. | D |
| 181 | Annexon Inc. US03589W1027 | 🇺🇸 US | $653 Mio. | D |
| 182 | Oxford Nanopore Technologies plc GB00BP6S8Z30 | 🇬🇧 GB | $1,6 Mrd. | D |
| 183 | Zentalis Pharmaceuticals Inc. US98943L1070 | 🇺🇸 US | $317 Mio. | D |
| 184 | Savior Lifetec Corp. TW0004167002 | 🇹🇼 TW | $201 Mio. | D |
| 185 | Protagonist Therapeutics Inc. US74366E1029 | 🇺🇸 US | $8,5 Mrd. | D |
| 186 | Dianthus Therapeutics Inc. US2528281080 | 🇺🇸 US | $3,9 Mrd. | D |
| 187 | Mesoblast Limited AU000000MSB8 | 🇦🇺 AU | $1,8 Mrd. | D |
| 188 | Karyopharm Therapeutics Inc. US48576U2050 | 🇺🇸 US | $218 Mio. | D |
| 189 | Centessa Pharmaceuticals plc US1523091007 | 🇬🇧 GB | $6,3 Mrd. | D |
| 190 | Monte Rosa Therapeutics Inc. US61225M1027 | 🇺🇸 US | $1,6 Mrd. | D |
| 191 | Tango Therapeutics Inc. US87583X1090 | 🇺🇸 US | $3,7 Mrd. | D |
| 192 | Arcus Biosciences Inc. US03969F1093 | 🇺🇸 US | $3,1 Mrd. | D |
| 193 | Zai Lab Limited KYG9887T1168 | 🇨🇳 CN | $2,2 Mrd. | D |
| 194 | Pharming Group N.V. NL0010391025 | 🇳🇱 NL | $984 Mio. | D |
| 195 | Biohaven Ltd. VGG1110E1079 | 🇺🇸 US | $1,7 Mrd. | D |
| 196 | Disc Medicine Inc. US2546041011 | 🇺🇸 US | $2,9 Mrd. | D |
| 197 | Phathom Pharmaceuticals Inc. US71722W1071 | 🇺🇸 US | $893 Mio. | D |
| 198 | Immunocore Holdings plc US45258D1054 | 🇬🇧 GB | $1,7 Mrd. | D |
| 199 | Caliway Biopharmaceuticals Co. L TW0006919004 | 🇹🇼 TW | $4,8 Mrd. | D |
| 200 | Xenon Pharmaceuticals Inc. CA98420N1050 | 🇨🇦 CA | $4,8 Mrd. | D |
| 201 | BioNTech SE US09075V1026 | 🇩🇪 DE | $24,7 Mrd. | D |
| 202 | Ocular Therapeutix Inc. US67576A1007 | 🇺🇸 US | $2,1 Mrd. | D |
| 203 | Abivax S.A. FR0012333284 | 🇫🇷 FR | $11,7 Mrd. | D |
| 204 | uniQure N.V. NL0010696654 | 🇳🇱 NL | $2,5 Mrd. | D |
| 205 | Geron Corporation US3741631036 | 🇺🇸 US | $872 Mio. | D |
| 206 | CanSino Biologics Inc. CNE100003F01 | 🇭🇰 HK | $1,0 Mrd. | D |
| 207 | Erasca Inc. US29479A1088 | 🇺🇸 US | $5,7 Mrd. | D |
| 208 | SELLAS Life Sciences Group Inc. US81642T2096 | 🇺🇸 US | $2,8 Mrd. | D |
| 209 | D&D Pharmatech KR7347850000 | 🇰🇷 KR | $2,3 Mrd. | D |
| 210 | Zenas BioPharma Inc. US98937L1052 | 🇺🇸 US | $1,2 Mrd. | D |
| 211 | Inhibrx Biosciences Inc. US45720N1037 | 🇺🇸 US | $1,4 Mrd. | D |
| 212 | Agios Pharmaceuticals Inc. US00847X1046 | 🇺🇸 US | $2,2 Mrd. | D |
| 213 | 4D Molecular Therapeutics Inc. US35104E1001 | 🇺🇸 US | $680 Mio. | D |
| 214 | Solid Biosciences Inc. US83422E2046 | 🇺🇸 US | $845 Mio. | D |
| 215 | Immunome Inc. US45257U1088 | 🇺🇸 US | $2,3 Mrd. | D |
| 216 | Viridian Therapeutics Inc. US92790C1045 | 🇺🇸 US | $1,7 Mrd. | D |
| 217 | Septerna Inc US81734D1046 | 🇺🇸 US | $1,5 Mrd. | D |
| 218 | OnKure Therapeutics Inc. US68277Q1058 | 🇺🇸 US | $63 Mio. | D |
| 219 | Monopar Therapeutics Inc. US61023L2079 | 🇺🇸 US | $655 Mio. | D |
| 220 | Xencor Inc. US98401F1057 | 🇺🇸 US | $1,1 Mrd. | D |
| 221 | Enliven Therapeutics Inc. US29337E1029 | 🇺🇸 US | $3,6 Mrd. | D |
| 222 | Relmada Therapeutics Inc. US75955J4022 | 🇺🇸 US | $659 Mio. | D |
| 223 | Celldex Therapeutics Inc. US15117B2025 | 🇺🇸 US | $2,6 Mrd. | D |
| 224 | Savara Inc. US8051111016 | 🇺🇸 US | $1,3 Mrd. | D |
| 225 | Oruka Therapeutics Inc. US6876041087 | 🇺🇸 US | $3,2 Mrd. | D |
| 226 | Relay Therapeutics Inc. US75943R1023 | 🇺🇸 US | $3,3 Mrd. | D |
| 227 | Replimune Group Inc. US76029N1063 | 🇺🇸 US | $972 Mio. | D |
| 228 | EyePoint Pharmaceuticals Inc. US30233G2093 | 🇺🇸 US | $1,2 Mrd. | D |
| 229 | Bicara Therapeutics Inc. Common Stock US0554771032 | 🇺🇸 US | $1,6 Mrd. | D |
| 230 | Allogene Therapeutics Inc. US0197701065 | 🇺🇸 US | $507 Mio. | D |
| 231 | Bioneer Corporation KR7064550007 | 🇰🇷 KR | $108 Mio. | D |
| 232 | GNI Group Ltd. JP3386370005 | 🇯🇵 JP | $988 Mio. | D |
| 233 | CStone Pharmaceuticals KYG2588M1006 | 🇨🇳 CN | $1,1 Mrd. | D |
| 234 | Keymed Biosciences Inc. KYG5252B1023 | 🇨🇳 CN | $2,9 Mrd. | D |
| 235 | CARsgen Therapeutics Holdings Limited KYG1996C1006 | 🇨🇳 CN | $1,1 Mrd. | D |
| 236 | Everest Medicines Limited KYG3224E1061 | 🇨🇳 CN | $1,1 Mrd. | D |
| 237 | LigaChem Biosciences Inc. KR7141080002 | 🇰🇷 KR | $3,2 Mrd. | D |
| 238 | Corvus Pharmaceuticals Inc. US2210151005 | 🇺🇸 US | $1,3 Mrd. | D |
| 239 | Lexicon Pharmaceuticals Inc. US5288723027 | 🇺🇸 US | $1,0 Mrd. | D |
| 240 | Prelude Therapeutics Incorporated US74065P1012 | 🇺🇸 US | $280 Mio. | D |
| 241 | AbCellera Biologics Inc. CA00288U1066 | 🇨🇦 CA | $2,5 Mrd. | D |
| 242 | Ascentage Pharma Group International KYG0519B1023 | 🇨🇳 CN | $1,7 Mrd. | D |
| 243 | OmniAb Inc. US68218J1034 | 🇺🇸 US | $288 Mio. | D |
| 244 | Absci Corporation US00091E1091 | 🇺🇸 US | $2,0 Mrd. | D |
| 245 | Maravai LifeSciences Holdings Inc. US56600D1072 | 🇺🇸 US | $1,7 Mrd. | D |
| 246 | Denali Therapeutics Inc. US24823R1059 | 🇺🇸 US | $4,1 Mrd. | D |
| 247 | Nurix Therapeutics Inc. US67080M1036 | 🇺🇸 US | $2,1 Mrd. | D |
| 248 | Tyra Biosciences Inc. US90240B1061 | 🇺🇸 US | $1,8 Mrd. | D |
| 249 | Codexis Inc. US1920051067 | 🇺🇸 US | $225 Mio. | D |
| 250 | Rezolute Inc. US76200L3096 | 🇺🇸 US | $473 Mio. | D |
| 251 | Sionna Therapeutics Inc. US8294011080 | 🇺🇸 US | $2,0 Mrd. | D |
| 252 | Zymeworks Inc. US98985Y1082 | 🇨🇦 CA | $1,9 Mrd. | D |
| 253 | Foghorn Therapeutics Inc. US3441741077 | 🇺🇸 US | $311 Mio. | D |
| 254 | OPKO Health Inc. US68375N1037 | 🇺🇸 US | $1,1 Mrd. | D |
| 255 | Amylyx Pharmaceuticals Inc. US03237H1014 | 🇺🇸 US | $1,5 Mrd. | D |
| 256 | Kyverna Therapeutics Inc. US5019761049 | 🇺🇸 US | $389 Mio. | D |
| 257 | Mineralys Therapeutics Inc. US6031701013 | 🇺🇸 US | $1,8 Mrd. | D |
| 258 | GH Research PLC IE000GID8VI0 | 🇮🇪 IE | $1,9 Mrd. | D |
| 259 | Ocumension Therapeutics KYG674111011 | 🇨🇳 CN | $508 Mio. | D |
| 260 | Agenus Inc. US00847G8042 | 🇺🇸 US | $145 Mio. | D |
| 261 | Vir Biotechnology Inc. US92764N1028 | 🇺🇸 US | $1,7 Mrd. | D |
| 262 | BioAge Labs Inc. US09077V1008 | 🇺🇸 US | $945 Mio. | D |
| 263 | Immatics N.V. NL0015285941 | 🇩🇪 DE | $1,3 Mrd. | D |
| 264 | Galectin Therapeutics Inc. US3632252025 | 🇺🇸 US | $297 Mio. | D |
| 265 | Design Therapeutics Inc. US25056L1035 | 🇺🇸 US | $977 Mio. | D |
| 266 | MBX Biosciences Inc. Common Stock US55287L1017 | 🇺🇸 US | $1,9 Mrd. | D |
| 267 | GRAIL Inc. US3847471014 | 🇺🇸 US | $3,0 Mrd. | D |
| 268 | LB Pharmaceuticals Inc Common Stock US50180M1080 | 🇺🇸 US | $959 Mio. | D |
| 269 | Ovid Therapeutics Inc. US6904691010 | 🇺🇸 US | $355 Mio. | D |
| 270 | Immix Biopharma Inc. US45258H1068 | 🇺🇸 US | $563 Mio. | D |
| 271 | AN2 Therapeutics Inc. US0373261058 | 🇺🇸 US | $121 Mio. | D |
| 272 | Tectonic Therapeutic Inc. US8789721086 | 🇺🇸 US | $716 Mio. | D |
| 273 | Recursion Pharmaceuticals Inc. US75629V1044 | 🇺🇸 US | $1,7 Mrd. | D |
| 274 | MacroGenics Inc. US5560991094 | 🇺🇸 US | $299 Mio. | D |
| 275 | Ocugen Inc. US67577C1053 | 🇺🇸 US | $511 Mio. | D |
| 276 | Alto Neuroscience Inc. US02157Q1094 | 🇺🇸 US | $870 Mio. | D |
| 277 | Damora Therapeutics Inc. US36322Q2066 | 🇺🇸 US | $1,8 Mrd. | D |
| 278 | Keros Therapeutics Inc. US4923271013 | 🇺🇸 US | $360 Mio. | D |
| 279 | Viking Therapeutics Inc. US92686J1060 | 🇺🇸 US | $4,3 Mrd. | D |
| 280 | Precision BioSciences Inc. US74019P2074 | 🇺🇸 US | $105 Mio. | D |
| 281 | Aclaris Therapeutics Inc. US00461U1051 | 🇺🇸 US | $671 Mio. | D |
| 282 | SK bioscience Co.Ltd. KR7302440003 | 🇰🇷 KR | $1,9 Mrd. | D |
| 283 | Sana Biotechnology Inc. US7995661045 | 🇺🇸 US | $1,1 Mrd. | D |
| 284 | C4 Therapeutics Inc. US12529R1077 | 🇺🇸 US | $356 Mio. | D |
| 285 | Orchestra BioMed Holdings Inc. US68572M1062 | 🇺🇸 US | $251 Mio. | D |
| 286 | SanBio Company Limited JP3336750009 | 🇯🇵 JP | $499 Mio. | D |
| 287 | Nektar Therapeutics US6402683063 | 🇺🇸 US | $1,4 Mrd. | D |
| 288 | Vanda Pharmaceuticals Inc. US9216591084 | 🇺🇸 US | $373 Mio. | D |
| 289 | Ginkgo Bioworks Holdings Inc. US37611X2099 | 🇺🇸 US | $679 Mio. | D |
| 290 | Climb Bio Inc. US28658R1068 | 🇺🇸 US | $880 Mio. | D |
| 291 | Green Cross Holdings Corporation KR7005250006 | 🇰🇷 KR | $303 Mio. | D |
| 292 | Rapport Therapeutics Inc. Common Stock US75383L1026 | 🇺🇸 US | $1,4 Mrd. | D |
| 293 | HLB Co. Ltd. KR7028300002 | 🇰🇷 KR | $4,1 Mrd. | D |
| 294 | Unicycive Therapeutics Inc. US90466Y2028 | 🇺🇸 US | $123 Mio. | D |
| 295 | Enanta Pharmaceuticals Inc. US29251M1062 | 🇺🇸 US | $351 Mio. | D |
| 296 | Alphamab Oncology KYG0330A1013 | 🇨🇳 CN | $916 Mio. | D |
| 297 | Shattuck Labs Inc. US82024L1035 | 🇺🇸 US | $338 Mio. | D |
| 298 | ARS Pharmaceuticals Inc. US82835W1080 | 🇺🇸 US | $850 Mio. | D |
| 299 | Alector Inc. US0144421072 | 🇺🇸 US | $229 Mio. | D |
| 300 | Sagimet Biosciences Inc. US7867001049 | 🇺🇸 US | $248 Mio. | D |
| 301 | Atai Beckley Inc. US04650F1012 | 🇺🇸 US | $1,9 Mrd. | D |
| 302 | Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. CNE100004090 | 🇨🇳 CN | $5,2 Mrd. | D |
| 303 | Jade Biosciences Inc. US0080642061 | 🇺🇸 US | $702 Mio. | D |
| 304 | Sutro Biopharma Inc. US8693672011 | 🇺🇸 US | $294 Mio. | D |
| 305 | Eledon Pharmaceuticals Inc. US28617K1016 | 🇺🇸 US | $237 Mio. | D |
| 306 | Candel Therapeutics Inc. US1374041093 | 🇺🇸 US | $540 Mio. | D |
| 307 | Valneva SE FR0004056851 | 🇫🇷 FR | $487 Mio. | D |
| 308 | Structure Therapeutics Inc. US86366E1064 | 🇺🇸 US | $3,1 Mrd. | D |
| 309 | Tenax Therapeutics Inc. US88032L6056 | 🇺🇸 US | $266 Mio. | D |
| 310 | Neurogene Inc. US64135M1053 | 🇺🇸 US | $558 Mio. | D |
| 311 | SAB Biotherapeutics Inc. US78397T2024 | 🇺🇸 US | $37 Mio. | D |
| 312 | Peptron Inc. KR7087010005 | 🇰🇷 KR | $2,6 Mrd. | D |
| 313 | Nuvectis Pharma Inc. US67080T1088 | 🇺🇸 US | $519 Mio. | D |
| 314 | Palisade Bio Inc. US6963894026 | 🇺🇸 US | $365 Mio. | D |
| 315 | TuHURA Biosciences Inc. US8989201038 | 🇺🇸 US | $138 Mio. | D |
| 316 | Spruce Biosciences Inc. US85209E2081 | 🇺🇸 US | $72 Mio. | D |
| 317 | Tonix Pharmaceuticals Holding Corp. US8902608392 | 🇺🇸 US | $197 Mio. | D |
| 318 | Aura Biosciences Inc. US05153U1079 | 🇺🇸 US | $497 Mio. | D |
| 319 | Contineum Therapeutics Inc. US21217B1008 | 🇺🇸 US | $565 Mio. | D |
| 320 | Neumora Therapeutics Inc. Common Stock US6409791000 | 🇺🇸 US | $309 Mio. | D |
| 321 | X4 Pharmaceuticals Inc. US98420X2027 | 🇺🇸 US | $390 Mio. | D |
| 322 | Whitehawk Therapeutics Inc US00032Q1040 | 🇺🇸 US | $207 Mio. | D |
| 323 | Vor Biopharma Inc. US9290332074 | 🇺🇸 US | $141 Mio. | D |
| 324 | Capricor Therapeutics Inc. US14070B3096 | 🇺🇸 US | $1,1 Mrd. | D |
| 325 | MaxCyte Inc. US57777K1060 | 🇺🇸 US | $133 Mio. | D |
| 326 | DiaMedica Therapeutics Inc. CA25253X2077 | 🇺🇸 US | $411 Mio. | D |
| 327 | Aardvark Therapeutics Inc. Common Stock US0029421007 | 🇺🇸 US | $105 Mio. | D |
| 328 | Nautilus Biotechnolgy Inc. US63909J1088 | 🇺🇸 US | $220 Mio. | D |
| 329 | Gossamer Bio Inc. US38341P1021 | 🇺🇸 US | $39 Mio. | D |
| 330 | Summit Therapeutics Inc. US86627T1088 | 🇺🇸 US | $12,0 Mrd. | D |
| 331 | Opus Genetics Inc. US67577R1023 | 🇺🇸 US | $349 Mio. | D |
| 332 | Century Therapeutics Inc. US15673T1007 | 🇺🇸 US | $210 Mio. | D |
| 333 | Editas Medicine Inc. US28106W1036 | 🇺🇸 US | $357 Mio. | D |
| 334 | Arcturus Therapeutics Holdings Inc. US03969T1097 | 🇺🇸 US | $207 Mio. | D |
| 335 | Crescent Biopharma Inc. KYG2545C1042 | 🇺🇸 US | $471 Mio. | D |
| 336 | Aldeyra The US01438T1060 | 🇺🇸 US | $137 Mio. | D |
| 337 | Bright Minds Biosciences Inc. CA10919W4056 | 🇨🇦 CA | $522 Mio. | D |
| 338 | Chongqing Zhifei Biological Products Co. Ltd. CNE100000V20 | 🇨🇳 CN | $4,3 Mrd. | D |
| 339 | Cabaletta Bio Inc. US12674W1099 | 🇺🇸 US | $520 Mio. | D |
| 340 | LENZ Therapeutics Inc. US52635N1037 | 🇺🇸 US | $185 Mio. | D |
| 341 | ORIC Pharmaceuticals Inc. US68622P1093 | 🇺🇸 US | $1,2 Mrd. | D |
| 342 | Heron Therapeutics Inc. US4277461020 | 🇺🇸 US | $69 Mio. | D |
| 343 | BINEX Co. Ltd. KR7053030003 | 🇰🇷 KR | $152 Mio. | D |
| 344 | Rocket Pharmaceuticals Inc. US77313F1066 | 🇺🇸 US | $419 Mio. | D |
| 345 | Artiva Biotherapeutics Inc. US04317A1079 | 🇺🇸 US | $238 Mio. | D |
| 346 | Oneness Biotech Co. Ltd. TW0004743000 | 🇹🇼 TW | $855 Mio. | D |
| 347 | Larimar Therapeutics Inc. US5171251003 | 🇺🇸 US | $279 Mio. | D |
| 348 | HLB Therapeutics Co.Ltd. KR7115450009 | 🇰🇷 KR | $124 Mio. | D |
| 349 | Nxera Pharma Co. Ltd. JP3431300007 | 🇯🇵 JP | $551 Mio. | D |
| 350 | Chabiotech Co.Ltd. KR7085660009 | 🇰🇷 KR | $511 Mio. | D |
| 351 | Fate Therapeutics Inc. US31189P1021 | 🇺🇸 US | $340 Mio. | D |
| 352 | Olema Pharmaceuticals Inc. US68062P1066 | 🇺🇸 US | $1,1 Mrd. | D |
| 353 | Zura Bio Limited KYG9TY5A1016 | 🇺🇸 US | $323 Mio. | D |
| 354 | Invivyd Inc. US00534A1025 | 🇺🇸 US | $263 Mio. | D |
| 355 | Maze Therapeutics Inc. US5787841007 | 🇺🇸 US | $1,7 Mrd. | D |
| 356 | ProKidney Corp. US74291D1046 | 🇺🇸 US | $683 Mio. | D |
| 357 | Daan Gene Co. Ltd. CNE000001KP1 | 🇨🇳 CN | $1,1 Mrd. | D |
| 358 | Ascletis Pharma Inc. KYG0520K1094 | 🇨🇳 CN | $1,6 Mrd. | D |
| 359 | Oculis Holding AG CH1242303498 | 🇨🇭 CH | $807 Mio. | D |
| 360 | MediWound Ltd. IL0011316309 | 🇮🇱 IL | $165 Mio. | D |
| 361 | Quantum-Si incorporated US74765K1051 | 🇺🇸 US | $184 Mio. | D |
| 362 | Avalo Therapeutics Inc. US05338F3064 | 🇺🇸 US | $213 Mio. | D |
| 363 | Atea Pharmaceuticals Inc. US04683R1068 | 🇺🇸 US | $399 Mio. | D |
| 364 | Cartesian Therapeutics Inc. US8162123025 | 🇺🇸 US | $311 Mio. | D |
| 365 | Milestone Pharmaceuticals Inc. CA59935V1076 | 🇨🇦 CA | $113 Mio. | D |
| 366 | Voyager Therapeutics Inc. US92915B1061 | 🇺🇸 US | $228 Mio. | D |
| 367 | Greenwich LifeSciences Inc. US3968791083 | 🇺🇸 US | $323 Mio. | D |
| 368 | Prime Medicine Inc. US74168J1016 | 🇺🇸 US | $699 Mio. | D |
| 369 | Arvinas Inc. US04335A1051 | 🇺🇸 US | $541 Mio. | D |
| 370 | CAMP4 Therapeutics Corporation US13463J1016 | 🇺🇸 US | $94 Mio. | D |
| 371 | CytomX Therapeutics Inc. US23284F1057 | 🇺🇸 US | $614 Mio. | D |
| 372 | Hebei Changshan Biochemical Pharmaceutical Co. Ltd. CNE1000016C2 | 🇨🇳 CN | $3,3 Mrd. | D |
| 373 | Immuneering Corporation US45254E1073 | 🇺🇸 US | $188 Mio. | D |
| 374 | ALX Oncology Holdings Inc. US00166B1052 | 🇺🇸 US | $279 Mio. | D |
| 375 | MoonLake Immunotherapeutics KY61559X1045 | 🇨🇭 CH | $1,4 Mrd. | D |
| 376 | Acumen Pharmaceuticals Inc. US00509G2093 | 🇺🇸 US | $166 Mio. | D |
| 377 | Duality Biotherapeutics Inc. KYG2929M1087 | 🇨🇳 CN | $2,4 Mrd. | D |
| 378 | Surrozen Inc. US86889P2083 | 🇺🇸 US | $186 Mio. | D |
| 379 | Voronoi Inc. KR7310210000 | 🇷🇴 RO | $2,1 Mrd. | D |
| 380 | Protara Therapeutics Inc. US74365U1079 | 🇺🇸 US | $157 Mio. | D |
| 381 | Akebia Therapeutics Inc. US00972D1054 | 🇺🇸 US | $333 Mio. | D |
| 382 | Janux Therapeutics Inc. US47103J1051 | 🇺🇸 US | $948 Mio. | D |
| 383 | REGENXBIO Inc. US75901B1070 | 🇺🇸 US | $687 Mio. | D |
| 384 | Prothena Corporation plc IE00B91XRN20 | 🇮🇪 IE | $507 Mio. | D |
| 385 | Lineage Cell Therapeutics Inc. US53566P1093 | 🇺🇸 US | $337 Mio. | D |
| 386 | Wave Life Sciences Ltd. SG9999014716 | 🇸🇬 SG | $1,2 Mrd. | D |
| 387 | ADC Therapeutics S.A. CH0499880968 | 🇨🇭 CH | $151 Mio. | D |
| 388 | Caribou Biosciences Inc. US1420381089 | 🇺🇸 US | $181 Mio. | D |
| 389 | Minerva Neurosciences Inc. US6033802058 | 🇺🇸 US | $36 Mio. | D |
| 390 | Coherus Oncology Inc. US19249H1032 | 🇺🇸 US | $177 Mio. | D |
| 391 | Assembly Biosciences Inc. US0453962070 | 🇺🇸 US | $441 Mio. | D |
| 392 | Benitec Biopharma Inc. US08205P2092 | 🇺🇸 US | $347 Mio. | D |
| 393 | PeptiDream Inc. JP3836750004 | 🇯🇵 JP | $817 Mio. | D |
| 394 | Forte Biosciences Inc. US34962G2084 | 🇺🇸 US | $290 Mio. | D |
| 395 | Orum Therapeutics Inc. KR7475830006 | 🇰🇷 KR | $686 Mio. | D |
| 396 | Humacyte Inc. US44486Q1031 | 🇺🇸 US | $119 Mio. | D |
| 397 | Elicio Therapeutics Inc. US28657F1030 | 🇺🇸 US | $61 Mio. | D |
| 398 | Lyell Immunopharma Inc. US55083R2031 | 🇺🇸 US | $328 Mio. | D |
| 399 | Gc Cell Corp. KR7144510005 | 🇰🇷 KR | $139 Mio. | D |
| 400 | Context Therapeutics Inc. US21077P1084 | 🇺🇸 US | $60 Mio. | D |
| 401 | Verastem Inc. US92337C2035 | 🇺🇸 US | $312 Mio. | D |
| 402 | GI Innovation Inc. KR7358570000 | 🇰🇷 KR | $370 Mio. | D |
| 403 | Entrada Therapeutics Inc. US29384C1080 | 🇺🇸 US | $300 Mio. | D |
| 404 | Lexeo Therapeutics Inc. Common Stock US52886X1072 | 🇺🇸 US | $368 Mio. | D |
| 405 | Tvardi Therapeutics Inc. US1407553072 | 🇺🇸 US | $22 Mio. | D |
| 406 | Cardiff Oncology Inc. US14147L1089 | 🇺🇸 US | $85 Mio. | D |
| 407 | Altimmune Inc. US02155H2004 | 🇺🇸 US | $279 Mio. | D |
| 408 | Lumosa Therapeutics Co. Ltd. TW0006535008 | 🇹🇼 TW | $564 Mio. | D |
| 409 | Compass Therapeutics Inc. US20454B1044 | 🇺🇸 US | $314 Mio. | D |
| 410 | Upstream Bio Inc. US91678A1079 | 🇺🇸 US | $409 Mio. | D |
| 411 | Fulcrum Therapeutics Inc. US3596161097 | 🇺🇸 US | $208 Mio. | D |
| 412 | aTyr Pharma Inc. US0021202025 | 🇺🇸 US | $52 Mio. | D |
| 413 | Tharimmune Inc. US4327053090 | 🇺🇸 US | $140 Mio. | D |
| 414 | Korro Bio Inc. US5009461089 | 🇺🇸 US | $139 Mio. | D |
| 415 | Corbus Pharmaceuticals Holdings Inc. US21833P3010 | 🇺🇸 US | $116 Mio. | D |
| 416 | Anavex Life Sciences Corp. US0327973006 | 🇺🇸 US | $256 Mio. | D |
| 417 | Black Diamond Therapeutics Inc. US09203E1055 | 🇺🇸 US | $115 Mio. | D |
| 1 | Vertex Pharmaceuticals Incorporated US92532F1003 | 🇺🇸 US | $134,0 Mrd. | A+ |
| 2 | Regeneron Pharmaceuticals Inc. US75886F1075 | 🇺🇸 US | $67,4 Mrd. | A+ |
| 3 | argenx SE NL0010832176 | 🇳🇱 NL | $58,4 Mrd. | A+ |
| 4 | UCB S.A. BE0003739530 | 🇧🇪 BE | $57,6 Mrd. | A+ |
| 5 | Lonza Group AG CH0013841017 | 🇨🇭 CH | $49,1 Mrd. | C |
| 6 | Revolution Medicines Inc. Warrant US76155X1182 | 🇺🇸 US | $43,4 Mrd. | D |
| 7 | Samsung Biologics Co.Ltd. KR7207940008 | 🇰🇷 KR | $43,2 Mrd. | B+ |
| 8 | Alnylam Pharmaceuticals Inc. US02043Q1076 | 🇺🇸 US | $41,8 Mrd. | B+ |
| 9 | CSL Limited AU000000CSL8 | 🇦🇺 AU | $40,2 Mrd. | C |
| 10 | Revolution Medicines Inc. US76155X1000 | 🇺🇸 US | $40,2 Mrd. | D |
| 11 | BeOne Medicines Ltd. Class A CNE100005XT6 | 🇨🇭 CH | $39,1 Mrd. | A |
| 12 | BeOne Medicines AG US07725L1026 | 🇺🇸 US | $31,8 Mrd. | A |
| 13 | Moderna Inc. US60770K1079 | 🇺🇸 US | $31,6 Mrd. | C |
| 14 | Celltrion Inc. KR7068270008 | 🇰🇷 KR | $26,2 Mrd. | B+ |
| 15 | Roivant Sciences Ltd. BMG762791017 | 🇬🇧 GB | $25,3 Mrd. | C |
| 16 | BioNTech SE US09075V1026 | 🇩🇪 DE | $24,7 Mrd. | D |
| 17 | Insmed Incorporated US4576693075 | 🇺🇸 US | $24,2 Mrd. | D |
| 18 | United Therapeutics Corporation US91307C1027 | 🇺🇸 US | $23,6 Mrd. | A+ |
| 19 | Incyte Corporation US45337C1027 | 🇺🇸 US | $23,3 Mrd. | A+ |
| 20 | Innovent Biologics Inc. KYG4818G1010 | 🇨🇳 CN | $19,4 Mrd. | B |
| 21 | WuXi Biologics (Cayman) Inc. KYG970081173 | 🇨🇳 CN | $18,5 Mrd. | A |
| 22 | Genmab A/S DK0010272202 | 🇩🇰 DK | $17,6 Mrd. | B |
| 23 | Neurocrine Biosciences Inc. US64125C1099 | 🇺🇸 US | $17,5 Mrd. | A+ |
| 24 | Ascendis Pharma A/S DKK085881034 | 🇩🇰 DK | $17,0 Mrd. | A |
| 25 | Jazz Pharmaceuticals plc IE00B4Q5ZN47 | 🇮🇪 IE | $15,3 Mrd. | C |
| 26 | BridgeBio Pharma Inc. US10806X1028 | 🇺🇸 US | $15,1 Mrd. | C |
| 27 | Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd. CNE1000062J1 | 🇨🇳 CN | $14,5 Mrd. | C |
| 28 | Exelixis Inc. US30161Q1040 | 🇺🇸 US | $14,0 Mrd. | A+ |
| 29 | Ionis Pharmaceuticals Inc. US4622221004 | 🇺🇸 US | $13,5 Mrd. | B+ |
| 30 | Haisco Pharmaceutical Group Co. Ltd. CNE100001BC7 | 🇨🇳 CN | $13,0 Mrd. | B |
| 31 | Axsome Therapeutics Inc. US05464T1043 | 🇺🇸 US | $12,6 Mrd. | B+ |
| 32 | Madrigal Pharmaceuticals Inc. US5588681057 | 🇺🇸 US | $12,2 Mrd. | C |
| 33 | Summit Therapeutics Inc. US86627T1088 | 🇺🇸 US | $12,0 Mrd. | D |
| 34 | Arrowhead Pharmaceuticals Inc. US04280A1007 | 🇺🇸 US | $11,8 Mrd. | D |
| 35 | Akeso Inc. KYG0146B1032 | 🇨🇳 CN | $11,7 Mrd. | D |
| 36 | Alteogen Inc. KR7196170005 | 🇰🇷 KR | $11,7 Mrd. | C |
| 37 | Abivax S.A. FR0012333284 | 🇫🇷 FR | $11,7 Mrd. | D |
| 38 | Financière de Tubize S.A. BE0003823409 | 🇧🇪 BE | $11,6 Mrd. | D |
| 39 | BioMarin Pharmaceutical Inc. US09061G1013 | 🇺🇸 US | $11,4 Mrd. | B+ |
| 40 | Bio-Techne Corporation US09073M1045 | 🇺🇸 US | $11,1 Mrd. | C |
| 41 | Krystal Biotech Inc. US5011471027 | 🇺🇸 US | $11,1 Mrd. | A+ |
| 42 | Cytokinetics Incorporated US23282W6057 | 🇺🇸 US | $10,8 Mrd. | D |
| 43 | Sichuan Kelun Pharmaceutical Co. Ltd. Class A CNE100000PW7 | 🇨🇳 CN | $10,5 Mrd. | B+ |
| 44 | ImmunityBio Inc. US45256X1037 | 🇺🇸 US | $9,9 Mrd. | C |
| 45 | Corcept Therapeutics Incorporated US2183521028 | 🇺🇸 US | $9,7 Mrd. | A+ |
| 46 | Halozyme Therapeutics Inc. US40637H1095 | 🇺🇸 US | $9,4 Mrd. | A+ |
| 47 | Kymera Therapeutics Inc. US5015751044 | 🇺🇸 US | $9,3 Mrd. | D |
| 48 | Nuvalent Inc. US6707031075 | 🇺🇸 US | $9,1 Mrd. | D |
| 49 | Alkermes plc IE00B56GVS15 | 🇮🇪 IE | $9,1 Mrd. | A |
| 50 | Shanghai Allist Pharmaceuticals Co. Ltd. CNE100005XJ7 | 🇨🇳 CN | $8,7 Mrd. | A |
| 51 | Protagonist Therapeutics Inc. US74366E1029 | 🇺🇸 US | $8,5 Mrd. | D |
| 52 | Vaxcyte Inc. US92243G1085 | 🇺🇸 US | $8,4 Mrd. | D |
| 53 | ALK-Abelló A/S DK0061802139 | 🇩🇰 DK | $8,3 Mrd. | A+ |
| 54 | Apogee Therapeutics Inc. US03770N1019 | 🇺🇸 US | $8,2 Mrd. | D |
| 55 | TG Therapeutics Inc. US88322Q1085 | 🇺🇸 US | $8,2 Mrd. | A+ |
| 56 | Immunovant Inc. US45258J1025 | 🇺🇸 US | $8,0 Mrd. | D |
| 57 | Rhythm Pharmaceuticals Inc. US76243J1051 | 🇺🇸 US | $7,8 Mrd. | C |
| 58 | Sunshine Guojian Pharmaceutical (Shanghai) Co. Ltd CNE1000062X2 | 🇨🇳 CN | $7,8 Mrd. | A+ |
| 59 | Asymchem Laboratories (Tianjin) Co. Ltd. CNE100002BZ6 | 🇨🇳 CN | $7,5 Mrd. | B+ |
| 60 | Liquidia Corporation US53635D2027 | 🇺🇸 US | $7,0 Mrd. | A |
| 61 | PTC Therapeutics Inc. US69366J2006 | 🇺🇸 US | $6,9 Mrd. | C |
| 62 | Praxis Precision Medicines Inc. US74006W2070 | 🇺🇸 US | $6,7 Mrd. | C |
| 63 | Cogent Biosciences Inc. US19240Q2012 | 🇺🇸 US | $6,6 Mrd. | D |
| 64 | Scholar Rock Holding Corporation US80706P1030 | 🇺🇸 US | $6,6 Mrd. | D |
| 65 | Ligand Pharmaceuticals Incorporated US53220K5048 | 🇺🇸 US | $6,4 Mrd. | A+ |
| 66 | Mirum Pharmaceuticals Inc. US6047491013 | 🇺🇸 US | $6,3 Mrd. | C |
| 67 | Centessa Pharmaceuticals plc US1523091007 | 🇬🇧 GB | $6,3 Mrd. | D |
| 68 | CG Oncology Inc. US1569441009 | 🇺🇸 US | $6,2 Mrd. | D |
| 69 | Biocon Limited INE376G01013 | 🇮🇳 IN | $6,0 Mrd. | B+ |
| 70 | CRISPR Therapeutics AG CH0334081137 | 🇨🇭 CH | $5,8 Mrd. | D |
| 71 | 3SBio Inc. KYG8875G1029 | 🇨🇳 CN | $5,8 Mrd. | B+ |
| 72 | Erasca Inc. US29479A1088 | 🇺🇸 US | $5,7 Mrd. | D |
| 73 | Legend Biotech Corporation US52490G1022 | 🇺🇸 US | $5,5 Mrd. | C |
| 74 | Hangzhou Tigermed Consulting Co. Ltd CNE1000040M1 | 🇨🇳 CN | $5,4 Mrd. | D |
| 75 | Shanghai Junshi Biosciences Co. Ltd. CNE1000041Z1 | 🇨🇳 CN | $5,4 Mrd. | D |
| 76 | Suzhou Zelgen Biopharmaceuticals Co. Ltd. CNE100003RP1 | 🇨🇳 CN | $5,3 Mrd. | C |
| 77 | Travere Therapeutics Inc. US89422G1076 | 🇺🇸 US | $5,3 Mrd. | B+ |
| 78 | Celcuity Inc. US15102K1007 | 🇺🇸 US | $5,3 Mrd. | D |
| 79 | Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. CNE100004090 | 🇨🇳 CN | $5,2 Mrd. | D |
| 80 | Spyre Therapeutics Inc. US00773J2024 | 🇺🇸 US | $5,2 Mrd. | D |
| 81 | Caris Life Sciences Inc. US1421521071 | 🇺🇸 US | $5,2 Mrd. | D |
| 82 | Definium Therapeutics Inc. CA24477V1058 | 🇺🇸 US | $4,8 Mrd. | D |
| 83 | Caliway Biopharmaceuticals Co. L TW0006919004 | 🇹🇼 TW | $4,8 Mrd. | D |
| 84 | Xenon Pharmaceuticals Inc. CA98420N1050 | 🇨🇦 CA | $4,8 Mrd. | D |
| 85 | Anthem Biosciences Ltd. INE0CZ201020 | 🇮🇳 IN | $4,6 Mrd. | A+ |
| 86 | Crinetics Pharmaceuticals Inc. US22663K1079 | 🇺🇸 US | $4,5 Mrd. | D |
| 87 | ACADIA Pharmaceuticals Inc. US0042251084 | 🇺🇸 US | $4,4 Mrd. | A |
| 88 | Shanghai RAAS Blood Products Co. Ltd. CNE100000C31 | 🇨🇳 CN | $4,4 Mrd. | C |
| 89 | SK Biopharmaceuticals Co. Ltd. KR7326030004 | 🇰🇷 KR | $4,4 Mrd. | C |
| 90 | Viking Therapeutics Inc. US92686J1060 | 🇺🇸 US | $4,3 Mrd. | D |
| 91 | Chongqing Zhifei Biological Products Co. Ltd. CNE100000V20 | 🇨🇳 CN | $4,3 Mrd. | D |
| 92 | Edgewise Therapeutics Inc. US28036F1057 | 🇺🇸 US | $4,3 Mrd. | D |
| 93 | Denali Therapeutics Inc. US24823R1059 | 🇺🇸 US | $4,1 Mrd. | D |
| 94 | HLB Co. Ltd. KR7028300002 | 🇰🇷 KR | $4,1 Mrd. | D |
| 95 | NewAmsterdam Pharma Company N.V. NL00150012L7 | 🇳🇱 NL | $4,1 Mrd. | D |
| 96 | Telix Pharmaceuticals Limited AU000000TLX2 | 🇦🇺 AU | $4,0 Mrd. | C |
| 97 | Dianthus Therapeutics Inc. US2528281080 | 🇺🇸 US | $3,9 Mrd. | D |
| 98 | Catalyst Pharmaceuticals Inc. US14888U1016 | 🇺🇸 US | $3,9 Mrd. | A+ |
| 99 | Dyne Therapeutics Inc. US26818M1080 | 🇺🇸 US | $3,8 Mrd. | D |
| 100 | Tango Therapeutics Inc. US87583X1090 | 🇺🇸 US | $3,7 Mrd. | D |
| 101 | Genscript Biotech Corporation KYG3825B1059 | 🇨🇳 CN | $3,6 Mrd. | D |
| 102 | Simcere Pharmaceutical Group Limited HK0000658531 | 🇨🇳 CN | $3,6 Mrd. | B+ |
| 103 | IDEAYA Biosciences Inc. US45166A1025 | 🇺🇸 US | $3,6 Mrd. | D |
| 104 | Beam Therapeutics Inc. US07373V1052 | 🇺🇸 US | $3,6 Mrd. | D |
| 105 | Enliven Therapeutics Inc. US29337E1029 | 🇺🇸 US | $3,6 Mrd. | D |
| 106 | Beijing Tiantan Biological Products Co. Ltd. CNE000000WF9 | 🇨🇳 CN | $3,5 Mrd. | C |
| 107 | Xiamen Amoytop Biotech Co. Ltd. CNE100003RT3 | 🇨🇳 CN | $3,5 Mrd. | B |
| 108 | Hualan Biological Engineering Inc. CNE000001JN8 | 🇨🇳 CN | $3,4 Mrd. | C |
| 109 | Adaptive Biotechnologies Corporation US00650F1093 | 🇺🇸 US | $3,4 Mrd. | C |
| 110 | Hebei Changshan Biochemical Pharmaceutical Co. Ltd. CNE1000016C2 | 🇨🇳 CN | $3,3 Mrd. | D |
| 111 | Zealand Pharma A/S DK0060257814 | 🇩🇰 DK | $3,3 Mrd. | B |
| 112 | Ultragenyx Pharmaceutical Inc. US90400D1081 | 🇺🇸 US | $3,3 Mrd. | D |
| 113 | Alumis Inc. US0223071020 | 🇺🇸 US | $3,3 Mrd. | D |
| 114 | Relay Therapeutics Inc. US75943R1023 | 🇺🇸 US | $3,3 Mrd. | D |
| 115 | Arcutis Biotherapeutics Inc. US03969K1088 | 🇺🇸 US | $3,2 Mrd. | C |
| 116 | Oruka Therapeutics Inc. US6876041087 | 🇺🇸 US | $3,2 Mrd. | D |
| 117 | LigaChem Biosciences Inc. KR7141080002 | 🇰🇷 KR | $3,2 Mrd. | D |
| 118 | Structure Therapeutics Inc. US86366E1064 | 🇺🇸 US | $3,1 Mrd. | D |
| 119 | Arcus Biosciences Inc. US03969F1093 | 🇺🇸 US | $3,1 Mrd. | D |
| 120 | BioArctic AB SE0010323311 | 🇸🇪 SE | $3,0 Mrd. | B |
| 121 | GRAIL Inc. US3847471014 | 🇺🇸 US | $3,0 Mrd. | D |
| 122 | Vera Therapeutics Inc. US92337R1014 | 🇺🇸 US | $3,0 Mrd. | D |
| 123 | Disc Medicine Inc. US2546041011 | 🇺🇸 US | $2,9 Mrd. | D |
| 124 | Keymed Biosciences Inc. KYG5252B1023 | 🇨🇳 CN | $2,9 Mrd. | D |
| 125 | Tarsus Pharmaceuticals Inc. US87650L1035 | 🇺🇸 US | $2,8 Mrd. | D |
| 126 | SELLAS Life Sciences Group Inc. US81642T2096 | 🇺🇸 US | $2,8 Mrd. | D |
| 127 | DaShenLin Pharmaceutical Group Co. Ltd. CNE100002RG2 | 🇨🇳 CN | $2,7 Mrd. | A |
| 128 | AnaptysBio Inc. US0327241065 | 🇺🇸 US | $2,7 Mrd. | B |
| 129 | Peptron Inc. KR7087010005 | 🇰🇷 KR | $2,6 Mrd. | D |
| 130 | Celldex Therapeutics Inc. US15117B2025 | 🇺🇸 US | $2,6 Mrd. | D |
| 131 | Trevi Therapeutics Inc. US89532M1018 | 🇺🇸 US | $2,5 Mrd. | D |
| 132 | uniQure N.V. NL0010696654 | 🇳🇱 NL | $2,5 Mrd. | D |
| 133 | AbCellera Biologics Inc. CA00288U1066 | 🇨🇦 CA | $2,5 Mrd. | D |
| 134 | Duality Biotherapeutics Inc. KYG2929M1087 | 🇨🇳 CN | $2,4 Mrd. | D |
| 135 | InnoCare Pharma Limited KYG4783B1032 | 🇨🇳 CN | $2,4 Mrd. | C |
| 136 | Biocytogen Pharmaceuticals (Beijing) Co. Ltd. CNE100005D27 | 🇨🇳 CN | $2,4 Mrd. | C |
| 137 | Vericel Corporation US92346J1088 | 🇺🇸 US | $2,4 Mrd. | B |
| 138 | Pharvaris N.V. NL00150005Y4 | 🇳🇱 NL | $2,4 Mrd. | D |
| 139 | D&D Pharmatech KR7347850000 | 🇰🇷 KR | $2,3 Mrd. | D |
| 140 | Immunome Inc. US45257U1088 | 🇺🇸 US | $2,3 Mrd. | D |
| 141 | Bavarian Nordic A/S DK0015998017 | 🇩🇰 DK | $2,2 Mrd. | B |
| 142 | Agios Pharmaceuticals Inc. US00847X1046 | 🇺🇸 US | $2,2 Mrd. | D |
| 143 | Zai Lab Limited KYG9887T1168 | 🇨🇳 CN | $2,2 Mrd. | D |
| 144 | Harmony Biosciences Holdings Inc. US4131971040 | 🇺🇸 US | $2,2 Mrd. | A+ |
| 145 | Ocular Therapeutix Inc. US67576A1007 | 🇺🇸 US | $2,1 Mrd. | D |
| 146 | Voronoi Inc. KR7310210000 | 🇷🇴 RO | $2,1 Mrd. | D |
| 147 | Nurix Therapeutics Inc. US67080M1036 | 🇺🇸 US | $2,1 Mrd. | D |
| 148 | ADMA Biologics Inc. US0008991046 | 🇺🇸 US | $2,1 Mrd. | C |
| 149 | BioCryst Pharmaceuticals Inc. US09058V1035 | 🇺🇸 US | $2,1 Mrd. | D |
| 150 | Genus plc GB0002074580 | 🇬🇧 GB | $2,1 Mrd. | C |
| 151 | Kodiak Sciences Inc. US50015M1099 | 🇺🇸 US | $2,0 Mrd. | D |
| 152 | Stoke Therapeutics Inc. US86150R1077 | 🇺🇸 US | $2,0 Mrd. | D |
| 153 | Sarepta Therapeutics Inc. US8036071004 | 🇺🇸 US | $2,0 Mrd. | D |
| 154 | Onesource Specialty Pharma Ltd. INE013P01021 | 🇮🇳 IN | $2,0 Mrd. | C |
| 155 | Aurinia Pharmaceuticals Inc. CA05156V1022 | 🇨🇦 CA | $2,0 Mrd. | A |
| 156 | Lakefront Biotherapeutics N.V. US36315X1019 | 🇧🇪 BE | $2,0 Mrd. | A+ |
| 157 | Anhui Anke Biotechnology (Group) Co. Ltd. CNE100000GY2 | 🇨🇳 CN | $2,0 Mrd. | C |
| 158 | Yunnan Botanee Bio-Technology Group Co.LTD CNE100004G74 | 🇨🇳 CN | $2,0 Mrd. | C |
| 159 | Sionna Therapeutics Inc. US8294011080 | 🇺🇸 US | $2,0 Mrd. | D |
| 160 | Lakefront Biotherapeutics BE0003818359 | 🇧🇪 BE | $2,0 Mrd. | A |
| 161 | Nuvation Bio Inc. US67080N1019 | 🇺🇸 US | $2,0 Mrd. | D |
| 162 | Intellia Therapeutics Inc. US45826J1051 | 🇺🇸 US | $2,0 Mrd. | D |
| 163 | Absci Corporation US00091E1091 | 🇺🇸 US | $2,0 Mrd. | D |
| 164 | Jinyu Bio-technology Co. Ltd. CNE000000Y37 | 🇨🇳 CN | $2,0 Mrd. | D |
| 165 | Nanobiotix S.A. FR0011341205 | 🇫🇷 FR | $2,0 Mrd. | C |
| 166 | MBX Biosciences Inc. Common Stock US55287L1017 | 🇺🇸 US | $1,9 Mrd. | D |
| 167 | OliX PharmaceuticalsInc KR7226950004 | 🇰🇷 KR | $1,9 Mrd. | D |
| 168 | Zymeworks Inc. US98985Y1082 | 🇨🇦 CA | $1,9 Mrd. | D |
| 169 | Syndax Pharmaceuticals Inc. US87164F1057 | 🇺🇸 US | $1,9 Mrd. | D |
| 170 | SK bioscience Co.Ltd. KR7302440003 | 🇰🇷 KR | $1,9 Mrd. | D |
| 171 | Atai Beckley Inc. US04650F1012 | 🇺🇸 US | $1,9 Mrd. | D |
| 172 | Syngene International Limited INE398R01022 | 🇮🇳 IN | $1,9 Mrd. | C |
| 173 | UroGen Pharma Ltd. IL0011407140 | 🇺🇸 US | $1,9 Mrd. | C |
| 174 | GH Research PLC IE000GID8VI0 | 🇮🇪 IE | $1,9 Mrd. | D |
| 175 | Damora Therapeutics Inc. US36322Q2066 | 🇺🇸 US | $1,8 Mrd. | D |
| 176 | Mesoblast Limited AU000000MSB8 | 🇦🇺 AU | $1,8 Mrd. | D |
| 177 | Mineralys Therapeutics Inc. US6031701013 | 🇺🇸 US | $1,8 Mrd. | D |
| 178 | Tyra Biosciences Inc. US90240B1061 | 🇺🇸 US | $1,8 Mrd. | D |
| 179 | Hugel Inc. KR7145020004 | 🇰🇷 KR | $1,8 Mrd. | B |
| 180 | Viridian Therapeutics Inc. US92790C1045 | 🇺🇸 US | $1,7 Mrd. | D |
| 181 | Palvella Therapeutics Inc. US6979471090 | 🇺🇸 US | $1,7 Mrd. | D |
| 182 | Maze Therapeutics Inc. US5787841007 | 🇺🇸 US | $1,7 Mrd. | D |
| 183 | Idorsia Ltd CH0363463438 | 🇨🇭 CH | $1,7 Mrd. | D |
| 184 | Recursion Pharmaceuticals Inc. US75629V1044 | 🇺🇸 US | $1,7 Mrd. | D |
| 185 | Precigen Inc. US74017N1054 | 🇺🇸 US | $1,7 Mrd. | D |
| 186 | Vir Biotechnology Inc. US92764N1028 | 🇺🇸 US | $1,7 Mrd. | D |
| 187 | Biohaven Ltd. VGG1110E1079 | 🇺🇸 US | $1,7 Mrd. | D |
| 188 | Ascentage Pharma Group International KYG0519B1023 | 🇨🇳 CN | $1,7 Mrd. | D |
| 189 | Maravai LifeSciences Holdings Inc. US56600D1072 | 🇺🇸 US | $1,7 Mrd. | D |
| 190 | Immunocore Holdings plc US45258D1054 | 🇬🇧 GB | $1,7 Mrd. | D |
| 191 | Innoviva Inc. US45781M1018 | 🇺🇸 US | $1,6 Mrd. | A |
| 192 | Fortrea Holdings Inc. US34965K1079 | 🇺🇸 US | $1,6 Mrd. | D |
| 193 | Taysha Gene Therapies Inc. US8776191061 | 🇺🇸 US | $1,6 Mrd. | D |
| 194 | ArriVent BioPharma Inc. US04272N1028 | 🇺🇸 US | $1,6 Mrd. | D |
| 195 | Oxford Nanopore Technologies plc GB00BP6S8Z30 | 🇬🇧 GB | $1,6 Mrd. | D |
| 196 | Novavax Inc. US6700024010 | 🇺🇸 US | $1,6 Mrd. | D |
| 197 | Bicara Therapeutics Inc. Common Stock US0554771032 | 🇺🇸 US | $1,6 Mrd. | D |
| 198 | Monte Rosa Therapeutics Inc. US61225M1027 | 🇺🇸 US | $1,6 Mrd. | D |
| 199 | Pharma Mar S.A. ES0169501022 | 🇪🇸 ES | $1,6 Mrd. | C |
| 200 | Ascletis Pharma Inc. KYG0520K1094 | 🇨🇳 CN | $1,6 Mrd. | D |
| 201 | Iovance Biotherapeutics Inc. US4622601007 | 🇺🇸 US | $1,5 Mrd. | D |
| 202 | Septerna Inc US81734D1046 | 🇺🇸 US | $1,5 Mrd. | D |
| 203 | Amylyx Pharmaceuticals Inc. US03237H1014 | 🇺🇸 US | $1,5 Mrd. | D |
| 204 | Neuren Pharmaceuticals Limited NZNEUE0001S8 | 🇦🇺 AU | $1,5 Mrd. | C |
| 205 | Inhibrx Biosciences Inc. US45720N1037 | 🇺🇸 US | $1,4 Mrd. | D |
| 206 | Xeris Biopharma Holdings Inc. US98422E1038 | 🇺🇸 US | $1,4 Mrd. | B |
| 207 | Rapport Therapeutics Inc. Common Stock US75383L1026 | 🇺🇸 US | $1,4 Mrd. | D |
| 208 | Concord Biotech Limited INE338H01029 | 🇮🇳 IN | $1,4 Mrd. | C |
| 209 | MannKind Corporation US56400P7069 | 🇺🇸 US | $1,4 Mrd. | D |
| 210 | MoonLake Immunotherapeutics KY61559X1045 | 🇨🇭 CH | $1,4 Mrd. | D |
| 211 | Nektar Therapeutics US6402683063 | 🇺🇸 US | $1,4 Mrd. | D |
| 212 | Immatics N.V. NL0015285941 | 🇩🇪 DE | $1,3 Mrd. | D |
| 213 | Ardelyx Inc. US0396971071 | 🇺🇸 US | $1,3 Mrd. | D |
| 214 | MeiraGTx Holdings plc KYG596651029 | 🇺🇸 US | $1,3 Mrd. | D |
| 215 | Corvus Pharmaceuticals Inc. US2210151005 | 🇺🇸 US | $1,3 Mrd. | D |
| 216 | Savara Inc. US8051111016 | 🇺🇸 US | $1,3 Mrd. | D |
| 217 | Zenas BioPharma Inc. US98937L1052 | 🇺🇸 US | $1,2 Mrd. | D |
| 218 | MedinCell S.A. FR0004065605 | 🇫🇷 FR | $1,2 Mrd. | D |
| 219 | ORIC Pharmaceuticals Inc. US68622P1093 | 🇺🇸 US | $1,2 Mrd. | D |
| 220 | Wave Life Sciences Ltd. SG9999014716 | 🇸🇬 SG | $1,2 Mrd. | D |
| 221 | EyePoint Pharmaceuticals Inc. US30233G2093 | 🇺🇸 US | $1,2 Mrd. | D |
| 222 | HBM Holdings Limited KYG4403H1002 | 🇨🇳 CN | $1,2 Mrd. | C |
| 223 | OPKO Health Inc. US68375N1037 | 🇺🇸 US | $1,1 Mrd. | D |
| 224 | CARsgen Therapeutics Holdings Limited KYG1996C1006 | 🇨🇳 CN | $1,1 Mrd. | D |
| 225 | Everest Medicines Limited KYG3224E1061 | 🇨🇳 CN | $1,1 Mrd. | D |
| 226 | Sana Biotechnology Inc. US7995661045 | 🇺🇸 US | $1,1 Mrd. | D |
| 227 | Xencor Inc. US98401F1057 | 🇺🇸 US | $1,1 Mrd. | D |
| 228 | Olema Pharmaceuticals Inc. US68062P1066 | 🇺🇸 US | $1,1 Mrd. | D |
| 229 | Daan Gene Co. Ltd. CNE000001KP1 | 🇨🇳 CN | $1,1 Mrd. | D |
| 230 | Capricor Therapeutics Inc. US14070B3096 | 🇺🇸 US | $1,1 Mrd. | D |
| 231 | CStone Pharmaceuticals KYG2588M1006 | 🇨🇳 CN | $1,1 Mrd. | D |
| 232 | Oxford Biomedica plc GB00BDFBVT43 | 🇬🇧 GB | $1,0 Mrd. | D |
| 233 | CanSino Biologics Inc. CNE100003F01 | 🇭🇰 HK | $1,0 Mrd. | D |
| 234 | Lexicon Pharmaceuticals Inc. US5288723027 | 🇺🇸 US | $1,0 Mrd. | D |
| 235 | Abbisko Cayman Limited KYG0028A1085 | 🇨🇳 CN | $1,0 Mrd. | C |
| 236 | GNI Group Ltd. JP3386370005 | 🇯🇵 JP | $988 Mio. | D |
| 237 | Kura Oncology Inc. US50127T1097 | 🇺🇸 US | $985 Mio. | D |
| 238 | Pharming Group N.V. NL0010391025 | 🇳🇱 NL | $984 Mio. | D |
| 239 | Design Therapeutics Inc. US25056L1035 | 🇺🇸 US | $977 Mio. | D |
| 240 | Replimune Group Inc. US76029N1063 | 🇺🇸 US | $972 Mio. | D |
| 241 | Lepu Biopharma Co. Ltd. CNE100004SM4 | 🇨🇳 CN | $964 Mio. | D |
| 242 | Arbutus Biopharma Corp CA03879J1003 | 🇺🇸 US | $962 Mio. | C |
| 243 | LB Pharmaceuticals Inc Common Stock US50180M1080 | 🇺🇸 US | $959 Mio. | D |
| 244 | Janux Therapeutics Inc. US47103J1051 | 🇺🇸 US | $948 Mio. | D |
| 245 | BioAge Labs Inc. US09077V1008 | 🇺🇸 US | $945 Mio. | D |
| 246 | Kuros Biosciences AG CH0325814116 | 🇨🇭 CH | $933 Mio. | D |
| 247 | Alphamab Oncology KYG0330A1013 | 🇨🇳 CN | $916 Mio. | D |
| 248 | Phathom Pharmaceuticals Inc. US71722W1071 | 🇺🇸 US | $893 Mio. | D |
| 249 | Climb Bio Inc. US28658R1068 | 🇺🇸 US | $880 Mio. | D |
| 250 | Theravance Biopharma Inc KYG8807B1068 | 🇺🇸 US | $873 Mio. | B+ |
| 251 | Geron Corporation US3741631036 | 🇺🇸 US | $872 Mio. | D |
| 252 | Alto Neuroscience Inc. US02157Q1094 | 🇺🇸 US | $870 Mio. | D |
| 253 | Oneness Biotech Co. Ltd. TW0004743000 | 🇹🇼 TW | $855 Mio. | D |
| 254 | ARS Pharmaceuticals Inc. US82835W1080 | 🇺🇸 US | $850 Mio. | D |
| 255 | Solid Biosciences Inc. US83422E2046 | 🇺🇸 US | $845 Mio. | D |
| 256 | Gubra A/S DK0062266474 | 🇩🇰 DK | $831 Mio. | B |
| 257 | Zevra Therapeutics Inc. US4884452065 | 🇺🇸 US | $826 Mio. | B+ |
| 258 | Basilea Pharmaceutica AG CH0011432447 | 🇨🇭 CH | $818 Mio. | C |
| 259 | PeptiDream Inc. JP3836750004 | 🇯🇵 JP | $817 Mio. | D |
| 260 | Oculis Holding AG CH1242303498 | 🇨🇭 CH | $807 Mio. | D |
| 261 | Rigel Pharmaceuticals Inc. US7665597024 | 🇺🇸 US | $716 Mio. | A+ |
| 262 | Tectonic Therapeutic Inc. US8789721086 | 🇺🇸 US | $716 Mio. | D |
| 263 | Jade Biosciences Inc. US0080642061 | 🇺🇸 US | $702 Mio. | D |
| 264 | Prime Medicine Inc. US74168J1016 | 🇺🇸 US | $699 Mio. | D |
| 265 | REGENXBIO Inc. US75901B1070 | 🇺🇸 US | $687 Mio. | D |
| 266 | CorMedix Inc. US21900C3088 | 🇺🇸 US | $686 Mio. | C |
| 267 | Orum Therapeutics Inc. KR7475830006 | 🇰🇷 KR | $686 Mio. | D |
| 268 | ProKidney Corp. US74291D1046 | 🇺🇸 US | $683 Mio. | D |
| 269 | 4D Molecular Therapeutics Inc. US35104E1001 | 🇺🇸 US | $680 Mio. | D |
| 270 | Ginkgo Bioworks Holdings Inc. US37611X2099 | 🇺🇸 US | $679 Mio. | D |
| 271 | Omeros Corporation US6821431029 | 🇺🇸 US | $672 Mio. | D |
| 272 | Gyre Therapeutics Inc. US4037831033 | 🇺🇸 US | $671 Mio. | D |
| 273 | Aclaris Therapeutics Inc. US00461U1051 | 🇺🇸 US | $671 Mio. | D |
| 274 | Relmada Therapeutics Inc. US75955J4022 | 🇺🇸 US | $659 Mio. | D |
| 275 | Achieve Life Sciences Inc. US0044685008 | 🇨🇦 CA | $657 Mio. | D |
| 276 | Esperion Therapeutics Inc. US29664W1053 | 🇺🇸 US | $657 Mio. | D |
| 277 | Monopar Therapeutics Inc. US61023L2079 | 🇺🇸 US | $655 Mio. | D |
| 278 | Annexon Inc. US03589W1027 | 🇺🇸 US | $653 Mio. | D |
| 279 | CytomX Therapeutics Inc. US23284F1057 | 🇺🇸 US | $614 Mio. | D |
| 280 | MiMedx Group Inc. US6024961012 | 🇺🇸 US | $588 Mio. | C |
| 281 | Contineum Therapeutics Inc. US21217B1008 | 🇺🇸 US | $565 Mio. | D |
| 282 | Lumosa Therapeutics Co. Ltd. TW0006535008 | 🇹🇼 TW | $564 Mio. | D |
| 283 | Immix Biopharma Inc. US45258H1068 | 🇺🇸 US | $563 Mio. | D |
| 284 | Neurogene Inc. US64135M1053 | 🇺🇸 US | $558 Mio. | D |
| 285 | Nxera Pharma Co. Ltd. JP3431300007 | 🇯🇵 JP | $551 Mio. | D |
| 286 | Arvinas Inc. US04335A1051 | 🇺🇸 US | $541 Mio. | D |
| 287 | Candel Therapeutics Inc. US1374041093 | 🇺🇸 US | $540 Mio. | D |
| 288 | XOMA Royalty Corp. US98419J2069 | 🇺🇸 US | $539 Mio. | D |
| 289 | Bright Minds Biosciences Inc. CA10919W4056 | 🇨🇦 CA | $522 Mio. | D |
| 290 | Cabaletta Bio Inc. US12674W1099 | 🇺🇸 US | $520 Mio. | D |
| 291 | Nuvectis Pharma Inc. US67080T1088 | 🇺🇸 US | $519 Mio. | D |
| 292 | Ocugen Inc. US67577C1053 | 🇺🇸 US | $511 Mio. | D |
| 293 | Chabiotech Co.Ltd. KR7085660009 | 🇰🇷 KR | $511 Mio. | D |
| 294 | Ocumension Therapeutics KYG674111011 | 🇨🇳 CN | $508 Mio. | D |
| 295 | Prothena Corporation plc IE00B91XRN20 | 🇮🇪 IE | $507 Mio. | D |
| 296 | Allogene Therapeutics Inc. US0197701065 | 🇺🇸 US | $507 Mio. | D |
| 297 | SanBio Company Limited JP3336750009 | 🇯🇵 JP | $499 Mio. | D |
| 298 | Aura Biosciences Inc. US05153U1079 | 🇺🇸 US | $497 Mio. | D |
| 299 | Valneva SE FR0004056851 | 🇫🇷 FR | $487 Mio. | D |
| 300 | Pharmicell Co. Ltd. KR7005690003 | 🇰🇷 KR | $477 Mio. | C |
| 301 | Rezolute Inc. US76200L3096 | 🇺🇸 US | $473 Mio. | D |
| 302 | Crescent Biopharma Inc. KYG2545C1042 | 🇺🇸 US | $471 Mio. | D |
| 303 | Assembly Biosciences Inc. US0453962070 | 🇺🇸 US | $441 Mio. | D |
| 304 | Emergent BioSolutions Inc. US29089Q1058 | 🇺🇸 US | $427 Mio. | D |
| 305 | Puma Biotechnology Inc. US74587V1070 | 🇺🇸 US | $420 Mio. | C |
| 306 | Rocket Pharmaceuticals Inc. US77313F1066 | 🇺🇸 US | $419 Mio. | D |
| 307 | DiaMedica Therapeutics Inc. CA25253X2077 | 🇺🇸 US | $411 Mio. | D |
| 308 | Upstream Bio Inc. US91678A1079 | 🇺🇸 US | $409 Mio. | D |
| 309 | Atea Pharmaceuticals Inc. US04683R1068 | 🇺🇸 US | $399 Mio. | D |
| 310 | X4 Pharmaceuticals Inc. US98420X2027 | 🇺🇸 US | $390 Mio. | D |
| 311 | Kyverna Therapeutics Inc. US5019761049 | 🇺🇸 US | $389 Mio. | D |
| 312 | Vanda Pharmaceuticals Inc. US9216591084 | 🇺🇸 US | $373 Mio. | D |
| 313 | GI Innovation Inc. KR7358570000 | 🇰🇷 KR | $370 Mio. | D |
| 314 | Lexeo Therapeutics Inc. Common Stock US52886X1072 | 🇺🇸 US | $368 Mio. | D |
| 315 | Abeona Therapeutics Inc. US00289Y2063 | 🇺🇸 US | $365 Mio. | C |
| 316 | Palisade Bio Inc. US6963894026 | 🇺🇸 US | $365 Mio. | D |
| 317 | Keros Therapeutics Inc. US4923271013 | 🇺🇸 US | $360 Mio. | D |
| 318 | Editas Medicine Inc. US28106W1036 | 🇺🇸 US | $357 Mio. | D |
| 319 | Clinuvel Pharmaceuticals Limited AU000000CUV3 | 🇦🇺 AU | $357 Mio. | B |
| 320 | C4 Therapeutics Inc. US12529R1077 | 🇺🇸 US | $356 Mio. | D |
| 321 | Ovid Therapeutics Inc. US6904691010 | 🇺🇸 US | $355 Mio. | D |
| 322 | Enanta Pharmaceuticals Inc. US29251M1062 | 🇺🇸 US | $351 Mio. | D |
| 323 | Opus Genetics Inc. US67577R1023 | 🇺🇸 US | $349 Mio. | D |
| 324 | Benitec Biopharma Inc. US08205P2092 | 🇺🇸 US | $347 Mio. | D |
| 325 | Fate Therapeutics Inc. US31189P1021 | 🇺🇸 US | $340 Mio. | D |
| 326 | Shattuck Labs Inc. US82024L1035 | 🇺🇸 US | $338 Mio. | D |
| 327 | Lineage Cell Therapeutics Inc. US53566P1093 | 🇺🇸 US | $337 Mio. | D |
| 328 | Akebia Therapeutics Inc. US00972D1054 | 🇺🇸 US | $333 Mio. | D |
| 329 | Medy-Tox Inc. KR7086900008 | 🇰🇷 KR | $332 Mio. | D |
| 330 | Lyell Immunopharma Inc. US55083R2031 | 🇺🇸 US | $328 Mio. | D |
| 331 | Greenwich LifeSciences Inc. US3968791083 | 🇺🇸 US | $323 Mio. | D |
| 332 | Zura Bio Limited KYG9TY5A1016 | 🇺🇸 US | $323 Mio. | D |
| 333 | Zentalis Pharmaceuticals Inc. US98943L1070 | 🇺🇸 US | $317 Mio. | D |
| 334 | Compass Therapeutics Inc. US20454B1044 | 🇺🇸 US | $314 Mio. | D |
| 335 | Verastem Inc. US92337C2035 | 🇺🇸 US | $312 Mio. | D |
| 336 | Foghorn Therapeutics Inc. US3441741077 | 🇺🇸 US | $311 Mio. | D |
| 337 | Cartesian Therapeutics Inc. US8162123025 | 🇺🇸 US | $311 Mio. | D |
| 338 | Neumora Therapeutics Inc. Common Stock US6409791000 | 🇺🇸 US | $309 Mio. | D |
| 339 | Fennec Pharmaceuticals Inc. CA31447P1009 | 🇺🇸 US | $304 Mio. | D |
| 340 | Green Cross Holdings Corporation KR7005250006 | 🇰🇷 KR | $303 Mio. | D |
| 341 | Entrada Therapeutics Inc. US29384C1080 | 🇺🇸 US | $300 Mio. | D |
| 342 | MacroGenics Inc. US5560991094 | 🇺🇸 US | $299 Mio. | D |
| 343 | Galectin Therapeutics Inc. US3632252025 | 🇺🇸 US | $297 Mio. | D |
| 344 | Sutro Biopharma Inc. US8693672011 | 🇺🇸 US | $294 Mio. | D |
| 345 | Forte Biosciences Inc. US34962G2084 | 🇺🇸 US | $290 Mio. | D |
| 346 | OmniAb Inc. US68218J1034 | 🇺🇸 US | $288 Mio. | D |
| 347 | PharmaEngine Inc. TW0004162003 | 🇹🇼 TW | $287 Mio. | C |
| 348 | Prelude Therapeutics Incorporated US74065P1012 | 🇺🇸 US | $280 Mio. | D |
| 349 | Larimar Therapeutics Inc. US5171251003 | 🇺🇸 US | $279 Mio. | D |
| 350 | Altimmune Inc. US02155H2004 | 🇺🇸 US | $279 Mio. | D |
| 351 | ALX Oncology Holdings Inc. US00166B1052 | 🇺🇸 US | $279 Mio. | D |
| 352 | Niagen Bioscience Inc US1710774076 | 🇺🇸 US | $273 Mio. | D |
| 353 | Tenax Therapeutics Inc. US88032L6056 | 🇺🇸 US | $266 Mio. | D |
| 354 | Invivyd Inc. US00534A1025 | 🇺🇸 US | $263 Mio. | D |
| 355 | Anavex Life Sciences Corp. US0327973006 | 🇺🇸 US | $256 Mio. | D |
| 356 | Orchestra BioMed Holdings Inc. US68572M1062 | 🇺🇸 US | $251 Mio. | D |
| 357 | Sagimet Biosciences Inc. US7867001049 | 🇺🇸 US | $248 Mio. | D |
| 358 | Artiva Biotherapeutics Inc. US04317A1079 | 🇺🇸 US | $238 Mio. | D |
| 359 | Eledon Pharmaceuticals Inc. US28617K1016 | 🇺🇸 US | $237 Mio. | D |
| 360 | Nkarta Inc. US65487U1088 | 🇺🇸 US | $230 Mio. | D |
| 361 | Alector Inc. US0144421072 | 🇺🇸 US | $229 Mio. | D |
| 362 | Voyager Therapeutics Inc. US92915B1061 | 🇺🇸 US | $228 Mio. | D |
| 363 | Codexis Inc. US1920051067 | 🇺🇸 US | $225 Mio. | D |
| 364 | Nautilus Biotechnolgy Inc. US63909J1088 | 🇺🇸 US | $220 Mio. | D |
| 365 | Karyopharm Therapeutics Inc. US48576U2050 | 🇺🇸 US | $218 Mio. | D |
| 366 | Avalo Therapeutics Inc. US05338F3064 | 🇺🇸 US | $213 Mio. | D |
| 367 | Century Therapeutics Inc. US15673T1007 | 🇺🇸 US | $210 Mio. | D |
| 368 | Fulcrum Therapeutics Inc. US3596161097 | 🇺🇸 US | $208 Mio. | D |
| 369 | Whitehawk Therapeutics Inc US00032Q1040 | 🇺🇸 US | $207 Mio. | D |
| 370 | Arcturus Therapeutics Holdings Inc. US03969T1097 | 🇺🇸 US | $207 Mio. | D |
| 371 | Savior Lifetec Corp. TW0004167002 | 🇹🇼 TW | $201 Mio. | D |
| 372 | Tonix Pharmaceuticals Holding Corp. US8902608392 | 🇺🇸 US | $197 Mio. | D |
| 373 | Immuneering Corporation US45254E1073 | 🇺🇸 US | $188 Mio. | D |
| 374 | Oramed Pharmaceuticals Inc. US68403P2039 | 🇺🇸 US | $188 Mio. | D |
| 375 | Protalix BioTherapeutics Inc. US74365A3095 | 🇺🇸 US | $187 Mio. | D |
| 376 | Surrozen Inc. US86889P2083 | 🇺🇸 US | $186 Mio. | D |
| 377 | LENZ Therapeutics Inc. US52635N1037 | 🇺🇸 US | $185 Mio. | D |
| 378 | Quantum-Si incorporated US74765K1051 | 🇺🇸 US | $184 Mio. | D |
| 379 | Caribou Biosciences Inc. US1420381089 | 🇺🇸 US | $181 Mio. | D |
| 380 | Coherus Oncology Inc. US19249H1032 | 🇺🇸 US | $177 Mio. | D |
| 381 | Acumen Pharmaceuticals Inc. US00509G2093 | 🇺🇸 US | $166 Mio. | D |
| 382 | MediWound Ltd. IL0011316309 | 🇮🇱 IL | $165 Mio. | D |
| 383 | Protara Therapeutics Inc. US74365U1079 | 🇺🇸 US | $157 Mio. | D |
| 384 | BINEX Co. Ltd. KR7053030003 | 🇰🇷 KR | $152 Mio. | D |
| 385 | ADC Therapeutics S.A. CH0499880968 | 🇨🇭 CH | $151 Mio. | D |
| 386 | Agenus Inc. US00847G8042 | 🇺🇸 US | $145 Mio. | D |
| 387 | Vor Biopharma Inc. US9290332074 | 🇺🇸 US | $141 Mio. | D |
| 388 | Tharimmune Inc. US4327053090 | 🇺🇸 US | $140 Mio. | D |
| 389 | Korro Bio Inc. US5009461089 | 🇺🇸 US | $139 Mio. | D |
| 390 | Gc Cell Corp. KR7144510005 | 🇰🇷 KR | $139 Mio. | D |
| 391 | TuHURA Biosciences Inc. US8989201038 | 🇺🇸 US | $138 Mio. | D |
| 392 | Aldeyra The US01438T1060 | 🇺🇸 US | $137 Mio. | D |
| 393 | MaxCyte Inc. US57777K1060 | 🇺🇸 US | $133 Mio. | D |
| 394 | HLB Therapeutics Co.Ltd. KR7115450009 | 🇰🇷 KR | $124 Mio. | D |
| 395 | Unicycive Therapeutics Inc. US90466Y2028 | 🇺🇸 US | $123 Mio. | D |
| 396 | AN2 Therapeutics Inc. US0373261058 | 🇺🇸 US | $121 Mio. | D |
| 397 | Humacyte Inc. US44486Q1031 | 🇺🇸 US | $119 Mio. | D |
| 398 | Corbus Pharmaceuticals Holdings Inc. US21833P3010 | 🇺🇸 US | $116 Mio. | D |
| 399 | Black Diamond Therapeutics Inc. US09203E1055 | 🇺🇸 US | $115 Mio. | D |
| 400 | Milestone Pharmaceuticals Inc. CA59935V1076 | 🇨🇦 CA | $113 Mio. | D |
| 401 | Bioneer Corporation KR7064550007 | 🇰🇷 KR | $108 Mio. | D |
| 402 | Precision BioSciences Inc. US74019P2074 | 🇺🇸 US | $105 Mio. | D |
| 403 | Aardvark Therapeutics Inc. Common Stock US0029421007 | 🇺🇸 US | $105 Mio. | D |
| 404 | CAMP4 Therapeutics Corporation US13463J1016 | 🇺🇸 US | $94 Mio. | D |
| 405 | Onconic Therapeutics KR7476060009 | 🇰🇷 KR | $89 Mio. | D |
| 406 | Cardiff Oncology Inc. US14147L1089 | 🇺🇸 US | $85 Mio. | D |
| 407 | Spruce Biosciences Inc. US85209E2081 | 🇺🇸 US | $72 Mio. | D |
| 408 | Heron Therapeutics Inc. US4277461020 | 🇺🇸 US | $69 Mio. | D |
| 409 | NRx Pharmaceuticals Inc. US6294442099 | 🇺🇸 US | $67 Mio. | D |
| 410 | OnKure Therapeutics Inc. US68277Q1058 | 🇺🇸 US | $63 Mio. | D |
| 411 | Elicio Therapeutics Inc. US28657F1030 | 🇺🇸 US | $61 Mio. | D |
| 412 | Context Therapeutics Inc. US21077P1084 | 🇺🇸 US | $60 Mio. | D |
| 413 | aTyr Pharma Inc. US0021202025 | 🇺🇸 US | $52 Mio. | D |
| 414 | Gossamer Bio Inc. US38341P1021 | 🇺🇸 US | $39 Mio. | D |
| 415 | SAB Biotherapeutics Inc. US78397T2024 | 🇺🇸 US | $37 Mio. | D |
| 416 | Minerva Neurosciences Inc. US6033802058 | 🇺🇸 US | $36 Mio. | D |
| 417 | Tvardi Therapeutics Inc. US1407553072 | 🇺🇸 US | $22 Mio. | D |